Finance

Affirm: Still Expensive After The Great Correction & Raised Guidance

Mar 11, 2025 - 14:51
 0
Affirm: Still Expensive After The Great Correction & Raised Guidance
Read More

Tags:

Previous Article

AMD: This Is The GARP Opportunity You've Been Waiting For (Rating Upgrade)

Next Article

Pfizer: Undervalued Safe Haven In Risk-Off Market​

Related Posts

Novartis Earnings Surprised The Street; Still Going Strong

Novartis Earnings Surprised The Street; Still Going Strong

Mar 6, 2025  0

Airbnb: 2025 Critical For Product Expansion

Mar 21, 2025  0

Rates Spark: Trump Wants A Lower 10yr Yield Too

Feb 6, 2025  0